RE:Newsletter outGuess it was... "The Company is preparing to launch a fifth Canadian clinical study site later in 4Q2020. Theralase® is in advanced discussions to launch a number of U.S. based clinical study sites in 4Q2020, subject to the United States economy recovering from the COVID-19 pandemic. The U.S. based Trial Management Organization (“TMO”) plans to launch 4 to 5 clinical study sites in 4Q2020 and commence Study II patient enrollment and treatment as early as 1Q2021."
Well, better than nothing :-)